---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-069785"
form_type: "8-K"
ticker: "AXSM"
cik: "0001579428"
company_name: "Axsome Therapeutics, Inc."
filed_at: "2025-05-13T23:59:59+00:00"
generated_at: "2026-05-21T15:58:15.285023+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Axsome enters $570M credit facility with Blackstone, retires Hercules loan

## Summary
- New $570M facility includes a $500M term loan (SOFR+4.75%) and a $70M revolver (SOFR+4.00%).
- Initially drew $120M to repay existing Hercules term loan; up to $250M additional draws available at company's option.
- Facility matures May 2030; 60-month interest-only period; expects significant reduction in interest expense.
- Blackstone also purchased $15M of common stock at $107.14 per share in a concurrent private placement.
- Company cites improved cost of capital and expanded credit capacity to support CNS pipeline growth.

## SEC filing metadata
- accession: 0000950170-25-069785
- form_type: 8-K
- ticker: AXSM
- cik: 0001579428
- company_name: Axsome Therapeutics, Inc.
- filed_at: 2025-05-13T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1579428/000095017025069785/0000950170-25-069785-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1579428/000095017025069785/axsm-20250508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-069785
- JSON: https://secwatch.observer/filing/0000950170-25-069785.json
- Plain text: https://secwatch.observer/filing/0000950170-25-069785.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.